Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: Consortium for improving survival of lymphoma (CISL) study
- Sung Yong Oh
- , Won Seog Kim
- , Jin Seok Kim
- , Seok Jin Kim
- , Dok Hyun Yoon
- , Deok Hwan Yang
- , Won Sik Lee
- , Hyo Jung Kim
- , Ho Young Yhim
- , Seong Hyun Jeong
- , Jong Ho Won
- , Suee Lee
- , Jee Hyun Kong
- , Sung Nam Lim
- , Jun Ho Ji
- , Kyung A. Kwon
- , Gyeong Won Lee
- , Jae Hoon Lee
- , Ho Sup Lee
- , Ho Jin Shin
*Corresponding author for this work
- Dong-A University
- Sungkyunkwan University
- Yonsei University
- University of Ulsan
- Chonnam National University
- Inje University
- Hallym University
- Ajou University
- Soonchunhyang University
- Yonsei University Wonju Severance Christian Hospital
- Dongnam Institute of Radiological and Medical Sciences
- Gyeongsang National University
- Gachon University
- Kosin University
- Pusan National University
Research output: Contribution to journal › Journal article › peer-review
17
Link opens in a new tab
Scopus
citations